spacer
home > pmps > winter 2001 > child-resistant clinical trials packaging
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Child-Resistant Clinical Trials Packaging

Many pharmaceutical companies operating on a global basis are worried by the Consumer Product and Safety Commission's (CPSC) enforcement (which began on 23rd November 2000) of child-resistant packaging for clinical trials packs containing a potentially hazardous amount of drug, as part of America's Poison Prevention Packaging Act (PPPA). This could have a knock-on effect for the packaging of clinical trials in Europe with the recent introduction of the EU GCP Clinical Trials Directive, signed in December 2000 and to be implemented into member states legislation within two years.

Consumer groups in Europe are campaigning for standards for child resistance compliance to be brought more in line with the US protocol.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Colin Scaife, Managing Partner of C.E. Packaging Partnership
Colin Scaife formed C.E. Packaging Partnership to provide small and medium-sized pharmaceutical and health care companies with independent access to packaging development expertise and help in their understanding of legislation. He has over 30 years' experience of the packaging of pharmaceutical, health care and FMCGH products and is keen to promote innovative and practical packaging. He is Chairman of the joint ABPI/PAGB technical working party, monitoring packaging issues on behalf of the industry. He is also a recognised expert in the field of child-resistant packaging, being the Convenor of both the European and international standards committees, through which he drafts standards for the testing of child-resistant packaging.

spacer
Colin Scaife
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo maintains its dual-terminal operations seamlessly

Completing the gradual transition process to Istanbul Airport, one of the largest airports of the world, the global air cargo brand Turkish Cargo maintains its dual-terminal operations with full capacity on 7/24 basis without any sales restriction.
More info >>

White Papers

Medpace Reference Laboratories establishes state of the art Flow Cytometry techniques for flexible approaches to clinical trials across multiple therapeutic areas.

Medpace

Cytometry is the process of measuring the properties of individual cells. These properties may include gene or protein expression, chemical properties, deoxyribonucleic acid (DNA) content, and various cellular functions. The earliest methods of cytometry relied upon light microscopy for the classification and observation of cells and cellular components. Microscopy permitted direct visual observation of cells for the first time, leading to the classification of cells by morphology and insight into cellular functions. However, the time required for microscopic analysis constrains the number of samples or number of cells in each sample that can be examined. Therefore, the utility of microscopy for analysis of rare cells or in situations where sample throughput is a priority is limited. Flow cytometry was developed largely to improve upon these limitations.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement